Spruce Biosciences, Inc. SPRB
46.61 USD +3.80 (+8.88%)
At closeNov 4, 2026, 4:01 PM EST
46.61 0.00 0.00%
After hours · Nov 4, 4:01 PM ET
44.43 Day range 46.61
38.06 52-week range 129.00
- YTD
- -46.49%
- 1 year
- -55.58%
Held by funds
38 US ETFs and mutual funds hold SPRB · largest positions
Ownership
Held by insiders 10.51%
Held by institutions 46.69%
Float held by institutions 52.17%
Institutions 37
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Rivervest Venture Management LLC | 7.11% | 2,936,281 | 1.11M | Sep 29, 2024 |
| Carlyle Group Inc. | 7.01% | 2,896,518 | 1.09M | Sep 29, 2024 |
| Rock Springs Capital Management, LP | 6.32% | 2,609,125 | 984.94K | Sep 29, 2024 |
| Acadian Asset Management. LLC | 3.05% | 1,259,151 | 475.33K | Sep 29, 2024 |
| Vanguard Group Inc | 2.04% | 843,844 | 318.55K | Sep 29, 2024 |
| Sands Capital Ventures, LLC | 1.91% | 787,007 | 297.10K | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.55% | 638,558 | 241.06K | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 0.48% | 197,187 | 74.44K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.37% | 153,228 | 57.84K | Oct 30, 2024 |
| Bridgeway Funds Inc-Ultra Small Company Market Fund | 0.10% | 40,000 | 15.10K | Sep 29, 2024 |
| Fidelity Series Total Market Index Fund | 0.09% | 36,510 | 13.78K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.08% | 31,503 | 11.89K | Oct 30, 2024 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CHARLTON RALPH WILLIAM III | Officer | Conversion of Exercise of derivative security | Dec 15, 2024 | 161,339 |
| GHARIB SAMIR M | President | Conversion of Exercise of derivative security | Dec 15, 2024 | 350,550 |
| NOVO HOLDINGS A/S | Beneficial Owner of more than 10% of a Class of Security | Sale | Mar 20, 2024 | 2,550,000 |
| O DONNELL NIALL | Director | Purchase | Feb 15, 2023 | 0 |
| ODONNELL NIALL | Director | Purchase | Feb 15, 2023 | 0 |
| SZWARCBERG JAVIER B M.D. | Chief Executive Officer | Conversion of Exercise of derivative security | Dec 15, 2024 | 467,191 |
